-
My Account
My Account
BSE Live
Mar 05, 16:00Prev. Close
914.90
Open Price
914.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 05, 15:58Prev. Close
919.00
Open Price
917.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Thyrocare Technologies (in Rs. Cr.) | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | |
| Net Sales/Income from operations | 433.20 | 402.91 | 356.32 | 304.39 | 231.25 | |
| Other Operating Income | -- | -- | -- | -- | 9.72 | |
| Total Income From Operations | 433.20 | 402.91 | 356.32 | 304.39 | 240.97 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 114.92 | 108.46 | 92.20 | 79.22 | 63.03 | |
| Purchase of Traded Goods | 2.25 | 2.33 | 2.41 | 2.56 | 6.64 | |
| Increase/Decrease in Stocks | -0.08 | -0.26 | 0.37 | -0.36 | 0.68 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 48.92 | 43.35 | 35.34 | 32.00 | 25.70 | |
| Depreciation | 31.91 | 26.17 | 20.10 | 18.05 | 18.24 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 94.67 | 94.80 | 81.28 | 75.78 | 51.41 | |
| P/L Before Other Inc., Int., Excpt. Items & Tax | 140.61 | 128.06 | 124.63 | 97.13 | 75.26 | |
| Other Income | 7.73 | 9.95 | 23.00 | 12.24 | 6.54 | |
| P/L Before Int., Excpt. Items & Tax | 148.34 | 138.01 | 147.62 | 109.38 | 81.80 | |
| Interest | 1.85 | 0.61 | 0.44 | 0.27 | -- | |
| P/L Before Exceptional Items & Tax | 146.49 | 137.40 | 147.19 | 109.11 | 81.80 | |
| Exceptional Items | -6.58 | -- | -2.19 | -27.43 | -- | |
| P/L Before Tax | 139.91 | 137.40 | 144.99 | 81.67 | 81.80 | |
| Tax | 52.01 | 52.92 | 51.72 | 38.83 | 30.00 | |
| P/L After Tax from Ordinary Activities | 87.90 | 84.48 | 93.28 | 42.85 | 51.80 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 87.90 | 84.48 | 93.28 | 42.85 | 51.80 | |
| Minority Interest | -- | -- | -- | -- | -- | |
| Share Of P/L Of Associates | 0.51 | 0.66 | -- | -- | -- | |
| Net P/L After M.I & Associates | 88.41 | 85.14 | 93.28 | 42.85 | 51.80 | |
| Equity Share Capital | 52.84 | 52.80 | 53.72 | 53.69 | 53.72 | |
| Reserves Excluding Revaluation Reserves | 310.09 | 378.44 | 389.57 | 354.12 | 311.89 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 16.74 | 15.95 | 17.39 | 7.99 | 10.06 | |
| Diluted EPS | 16.71 | 15.91 | 17.34 | 8.13 | 10.06 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 16.74 | 15.95 | 17.39 | 7.99 | 10.06 | |
| Diluted EPS. | 16.71 | 15.91 | 17.34 | 8.13 | 10.06 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
08.08.2020
Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
